Skip to main content
OpenTrials
Completed

NCT Number: NCT01622166

Art Therapy in Acute Schizophrenia

Randomised, controlled, single-blinded pilot study to assess the efficacy of psychodynamic art therapy in a sample of hospitalized, (sub)acutely psychotic patients with a diagnosis of schizophrenia compared to a group of patients receiving treatment as usual.

*Main hypothesis: Art therapy has no impact on clinical symptoms and the course of remission compared to TAU.

*Exploratory hypotheses: Art therapy has no influence on quality of life, mentalizing function, self-efficacy and neuroleptic dosage compared to TAU.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Schizophrenia Mental Disorders Schizophrenia Spectrum and Other Psychotic Disorders

Age range

18 year–64 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Psychiatrische Universitätsklinik der Charité im St. Hedwig Krankenhaus

Berlin, 10115, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosis of schizophrenia according to DSM-IV-TR
  • age 18-64 yrs
  • sufficient German language competency
  • written informed consent

Exclusion criteria

  • axis-I mental disorders other than schizophrenia
  • comorbid antisocial personality disorder, relevant substance abuse,
  • relevant severe somatic disease
  • acute suicidal tendencies or aggression
  • incapability to tolerate group settings

Treatment and study plan

psychodynamic art therapy

Behavioral

2 sessions à 1.5 hrs /week, intervention duration 6 weeks

Primary outcomes

  1. Change in Positive and Negative Syndrome Scale (PANSS-) scores

    Time frame: weeks 0, 6, 12

    assessment of change of schizophrenic positive, negative and general symptom scores

  2. safety measures

    Time frame: weeks 0, 6, 12

    number of participants with adverse events

  3. Change in Calgary depression Scale (CDS-) scores

    Time frame: weeks 0, 6, 12

    assessment of change of depressive symptoms in schizophrenic patients as reflected by CDS-scores

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Collaborators

  • Prof. K. Dannecker, Kunsttherapie Berlin Kunsthochschule Berlin-Weißensee

Registry information

Official study title

Art Therapy for Symptom Reduction in Acute Schizophrenia - a Randomised Controlled Trial (Kunsttherapie Zur Symptomreduktion Bei Akuter Schizophrenie - Eine Randomisierte Kontrollierte Pilotstudie)

Acronym: KUSS

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Jun 19, 2012
Registry last updated
Oct 24, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.